Aleris-Hamlet Hospital
Frederiksberg, Denmark
NCT Number: NCT01463865
In this study the investigators wish to compare the effect of a selective axillary nerve block to placebo in patients undergoing arthroscopic shoulder surgery.
It is the investigators hypothesis that the amount of morphine consumption in the first 4 hours postoperatively in the intervention group will be significant lower than in the placebo group.
Looking for future studies?
Notify Me18 year–80 year
All sexes
Interventional
Not applicable
Frederiksberg, Denmark
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Single shot nerve block with ropivacaine 10-20 ml; 7,5 mg/ml
Other names: Naropin
Single shot nerve block with isotonic sodiumchloride 10-20 ml; 0.9%
Time frame: 0-4 hours postoperatively
Patients are coupled to an intravenous PCA pump. The amount of morphine administered by the patient in the first 4 hours postoperatively is registered.
Time frame: 0-12 hours and 12-24 hours postoperatively
Postoperative VAS scores during the first 24 hours postoperatively, divided into two periods.
Time frame: 0-24 hours postoperatively
The total amount of morphine administered during the first 24 hours postoperatively
Time frame: 0-4, 0-12 and 12-24 hours postoperatively
Postoperative nausea evaluated on a 1-3 scale with and without vomiting
Time frame: 0-4 hours postoperatively
The use of an escape block (interscalene brachial plexus block) in patients with pain breakthrough despite IV morphine 0-4 hours postoperatively.
Time frame: 0-4 hours postoperatively
Number of morphine boli administered during the first 4 hours postoperatively
Hillerod Hospital, Denmark
Other
Selective Block of the Axillary Nerve in Postoperative Pain Management, a Randomised, Blinded, Placebo-controlled Trial
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05283980
Acute Pain, Behavior
Boston, Massachusetts, United States
View Trial DetailsNCT05859061
Neurologic Manifestations, Pain
Chicago, Illinois, United States
View Trial DetailsNCT06791577
Blood Coagulation Disorders, Bruising
São Paulo, Brazil
View Trial DetailsNCT03090776
Neurologic Manifestations, Pain
Boston, Massachusetts, United States
View Trial Details